Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 3 | 2024 | 532 | 0.420 |
Why?
|
| Mass Screening | 2 | 2021 | 531 | 0.400 |
Why?
|
| Risk Assessment | 1 | 2016 | 845 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 744 | 0.390 |
Why?
|
| Hospitals, Public | 1 | 2024 | 14 | 0.220 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 729 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 90 | 0.210 |
Why?
|
| Internship and Residency | 2 | 2024 | 141 | 0.210 |
Why?
|
| Prediabetic State | 1 | 2024 | 68 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 107 | 0.200 |
Why?
|
| Masks | 1 | 2023 | 15 | 0.200 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 62 | 0.190 |
Why?
|
| Risk Factors | 6 | 2024 | 3942 | 0.190 |
Why?
|
| Staphylococcal Infections | 1 | 2023 | 65 | 0.190 |
Why?
|
| Trauma Centers | 1 | 2022 | 92 | 0.180 |
Why?
|
| Coronary Vessels | 1 | 2021 | 92 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2021 | 25 | 0.170 |
Why?
|
| Lead Poisoning | 1 | 2021 | 25 | 0.170 |
Why?
|
| Adult | 10 | 2024 | 13458 | 0.170 |
Why?
|
| Postoperative Complications | 1 | 2022 | 253 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 223 | 0.160 |
Why?
|
| Lead | 1 | 2021 | 101 | 0.160 |
Why?
|
| Humans | 16 | 2024 | 42163 | 0.140 |
Why?
|
| Telemedicine | 1 | 2021 | 215 | 0.140 |
Why?
|
| Administrative Personnel | 1 | 2017 | 11 | 0.130 |
Why?
|
| Young Adult | 4 | 2024 | 4936 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2016 | 95 | 0.130 |
Why?
|
| ROC Curve | 1 | 2016 | 157 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 180 | 0.120 |
Why?
|
| Female | 9 | 2024 | 24018 | 0.120 |
Why?
|
| Propensity Score | 2 | 2024 | 58 | 0.110 |
Why?
|
| Male | 7 | 2024 | 22779 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2016 | 386 | 0.110 |
Why?
|
| Inservice Training | 1 | 2014 | 33 | 0.110 |
Why?
|
| Indians, North American | 1 | 2016 | 179 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1001 | 0.100 |
Why?
|
| Chlamydiaceae Infections | 1 | 2012 | 3 | 0.100 |
Why?
|
| Calcitriol | 1 | 2012 | 32 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 69 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2024 | 2485 | 0.090 |
Why?
|
| Chlamydia muridarum | 1 | 2012 | 104 | 0.090 |
Why?
|
| Georgia | 2 | 2023 | 189 | 0.090 |
Why?
|
| Health Education | 1 | 2014 | 358 | 0.090 |
Why?
|
| Incidence | 2 | 2024 | 1054 | 0.080 |
Why?
|
| Child | 3 | 2023 | 3381 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2024 | 1729 | 0.080 |
Why?
|
| HIV Infections | 1 | 2022 | 2535 | 0.070 |
Why?
|
| Middle Aged | 4 | 2024 | 11819 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 959 | 0.070 |
Why?
|
| Aged | 3 | 2024 | 7982 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 5950 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2024 | 42 | 0.060 |
Why?
|
| Mississippi | 1 | 2024 | 129 | 0.050 |
Why?
|
| Infertility | 1 | 2024 | 21 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 183 | 0.050 |
Why?
|
| Southeastern United States | 1 | 2023 | 58 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 118 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 263 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 91 | 0.050 |
Why?
|
| Vitamin D | 1 | 2024 | 196 | 0.050 |
Why?
|
| Censuses | 1 | 2021 | 28 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 40 | 0.040 |
Why?
|
| Schools | 1 | 2023 | 283 | 0.040 |
Why?
|
| United States | 2 | 2024 | 5072 | 0.040 |
Why?
|
| Insulin | 1 | 2021 | 255 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1597 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 680 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2021 | 247 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1020 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 359 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3077 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 176 | 0.030 |
Why?
|
| Exercise | 1 | 2021 | 674 | 0.030 |
Why?
|
| Health Policy | 1 | 2017 | 184 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 398 | 0.030 |
Why?
|
| Problem Solving | 1 | 2014 | 38 | 0.030 |
Why?
|
| Leadership | 1 | 2014 | 84 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 110 | 0.020 |
Why?
|
| Leukocyte Elastase | 1 | 2012 | 12 | 0.020 |
Why?
|
| Peer Group | 1 | 2014 | 173 | 0.020 |
Why?
|
| Serpins | 1 | 2012 | 29 | 0.020 |
Why?
|
| Internet | 1 | 2014 | 234 | 0.020 |
Why?
|
| Hela Cells | 1 | 2012 | 370 | 0.020 |
Why?
|
| Proteome | 1 | 2012 | 150 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1804 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1066 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2598 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 6490 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 16695 | 0.010 |
Why?
|